We use cookies for a better user experience. Read our Privacy Policy
I Agree
Orthobiologics Market
Analysts’ Viewpoint on Orthobiologics Market Scenario
Orthobiologics are being regularly used in orthopedic surgeries and sports medicines since the last few years. The global orthobiologics market is likely to be driven by the rise in rate of sports injuries, ongoing influx of new products & treatment options, advancements in the field of regenerative medicine, and growth in demand for minimally invasive surgeries. However, the COVID-19 pandemic has led to a slowdown in research in the fields of musculoskeletal tissue engineering and regenerative medicine. Nevertheless, high growth potential in emerging countries and increase in demand for advanced treatments are projected to present significant opportunities for orthobiologics companies during the forecast period.
Orthobiologics encompass a broad range of technologies with a biological or biochemical component. Examples include biologic factors delivered through a device, bone graft materials, cell therapies, and resorbable scaffolds to reinforce soft tissue. Rise in usage of orthobiologics products and orthopedic devices, and the integration of biology and biochemistry in the treatment of bone and soft tissue injuries are driving the orthobiologics market. Orthobiologics are medications that speed up the body's natural healing process. They can help repair osteoarthritis damage as well as accelerate the recovery of strained muscles, tendons, and ligaments. Orthobiologics are made with components that are naturally found in the human body. Rise in prevalence of inflammatory conditions such as osteoarthritis and tendinitis along with increase in participation in a sports activity that can lead to ligament or muscle injury in teenagers and young adults is expected to drive the global orthobiologics market during the forecast period. Orthobiologics, which has the potential to accelerate the healing process for pain and injuries, provides solutions and hope for people who want to live a pain-free life.
Request a sample to get extensive insights into the Orthobiologics Market
Sports injuries have become a major concern for athletes. The musculoskeletal system, which consists of the muscles, tendons, ligaments, fascia, nerves, bones, and tissues, is involved in sports injuries. Falls, excessive exertion, and fractures are the primary causes of these injuries. Lower and upper extremities suffer the majority of sports-related injuries and muscle injuries. Orthobiologics, such as stem cells, are used to treat common, acute, and chronic sports injuries. Year-round participation in a single sport is the most significant cause of increase in youth injuries. Rugby, combat sports, field hockey, basketball, and handball account for the most number of hand injuries.
In the last few decades, there has been an increase in sports participation by children and adolescents at an early age in the U.S. There has also been a rise in specialization in sports at a very early age. This trend has contributed to the patterns of injuries seen in young athletes. Injuries previously observed in mature athletes are now being reported in young athletes. According to a study published by the National Library of Medicine, 3.5 million youth under the age of 15 receive medical care each year in the U.S. for injuries sustained during sports practice.
In terms of product, the viscosupplements segment held significant market share in 2021. Increase in demand for non-surgical treatments for osteoarthritis, rise in prevalence of lifestyle-induced disorders, and advancements in hyaluronic acid-based therapies are expected to drive the viscosupplements segment during the forecast period. Viscosupplements demonstrate clinical efficacy and is the most effective treatment for knee osteoarthritis. Osteoarthritis is the most common joint disorder in the U.S., affecting nearly 27 million people. Osteoarthritis of the knee alone affects 10% of men and 13% of women over the age of 60. Viscosupplementation can significantly reduce pain while improving joint mobility and function, making daily activities and even athletic or strenuous exercise less painful. Manufacturers of viscosupplementation devices are striving to develop and get approval for new medicines to treat osteoarthritis of the elbow, hip, and knee.
Request a custom report on Orthobiologics Market
The spinal fusion segment accounted for the largest share of the global orthobiologics market in 2021. The segment is expected to be driven by the increase in number of spinal injuries and sports-related injuries during the forecast period. Demand for spinal fusion devices has been rising across the globe. Majority of spinal cord injuries are caused by avoidable incidences such as car accidents, falls, or violence. Traumatic spinal injury (TSI) occurs when bony, ligamentous, and/or neurologic structures of the spinal column are injured and result in significant morbidity and mortality.
In terms of end-user, the hospitals segment is projected to account for a major share of the global orthobiologics market during the forecast period. Orthopedic surgery is performed in hospitals on various parts such as the shoulder, ankle, hip, knee, wrists, elbow, and spine, depending on the type of injury or damage. Knee joint replacement, arthroscopy, pediatric orthopedic, and other minimally invasive orthopedic surgeries are the most commonly recommended procedures. Hence, the hospitals segment is likely to capture significant market share during the forecast period. Surgeries were traditionally performed in hospitals; however, advances in technology, anesthesia, and pain control now allow physicians to perform certain procedures in an orthopedic clinic center. This is projected to drive the orthopedic clinics segment in the next few years.
North America accounted for the largest share of around 45% of the global orthobiologics market in 2021. It is projected to be a highly lucrative region of the global market during the forecast period. Increase in demand for orthobiologics products, highly developed healthcare system, and availability of advanced therapy for orthopedic treatment are the factors driving the market in North America. The U.S. dominated the market in North America in 2021 due to the significant increase in spine injuries caused by falls and accidents in the country. According to the Department of Health and Human Services, two million people in the country suffer from sports-related injuries every year. There is also a greater understanding of orthobiologics and its benefits, such as accelerated healing capabilities, faster recoveries, and fewer hospital visits.
The market in Asia Pacific is expected to grow at a rapid pace during the forecast period. Rise in geriatric and target patient population, high incidence of osteoarthritis and obesity, increase in government healthcare spending, and improved healthcare infrastructure are the major factors driving the market in the region. Furthermore, Asia Pacific was the leading market for non-industry-sponsored osteoarthritis trials, accounting for a significant share in 2021.
The global orthobiologics market is consolidated, with the presence of small number of leading players. Expansion of product portfolio and mergers & acquisitions are the key strategies adopted by the leading players in the global orthobiologics market. Alphatec Spine, Inc., Integra Life Sciences, DePuy Synthes, Seikagaku Corporation, Arthrex, RTI Surgical, Inc., MTF Biologics, Exactech, Inc., Johnson & Johnson, Sanofi, and Stryker are the prominent players operating in the global orthobiologics market.
Each of these players has been profiled in the orthobiologics market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 5.01 Bn |
|
Market Forecast Value in 2031 |
More than US$ 7.4 Bn |
|
Growth Rate (CAGR) |
4.7% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2020 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Interested in this report?
Get a FREE Brochure now!
*Get Brochure Report (PDF) sent to your email within minutes
The global orthobiologics market was valued at US$ 5.01 Bn in 2021.
The global orthobiologics market is projected to reach more than US$ 7.4 Bn by 2031.
The global orthobiologics market is anticipated to grow at a CAGR of 4.7% from 2022 to 2031.
Increase in incidence of sports injuries and road accidents is driving the global orthobiologics market.
North America is expected to account for major share of the global market during the forecast period.
Prominent players in the global orthobiologics market include Alphatec Spine, Inc., Integra Life Sciences, DePuy Synthes, Seikagaku Corporation, Arthrex, RTI Surgical, Inc., MTF Biologics, Exactech, Inc., Johnson & Johnson, Integra Life Sciences, Sanofi, and Stryker.
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Orthobiologics Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Orthobiologics Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Key Market Trends
5.2. Merger and Acquisition
5.3. Strategies of Top Five Players Operating in the Market
5.4. Incidence of Orthopedic Disorder, by Key Countries
5.5. Regulatory and Reimbursement Scenario, by Key Countries
6. Global Orthobiologics Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Market Value Forecast, by Product, 2017–2031
6.2.1. Demineralized Bone Matrix
6.2.2. Allografts
6.2.3. Synthetic Bone Substitutes
6.2.4. Viscosupplements
6.2.5. Bone Morphogenetic Proteins
6.2.6. Stem Cell Therapy
6.2.7. Others
6.3. Market Attractiveness, by Product
7. Global Orthobiologics Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Market Value Forecast, by Application, 2017–2031
7.2.1. Spinal Fusion
7.2.2. Trauma Repair
7.2.3. Reconstructive Surgeries
7.2.4. Others
7.3. Market Attractiveness Analysis, by Application
8. Global Orthobiologics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Market Value Forecast, by End-user, 2017–2031
8.2.1. Hospitals
8.2.2. Orthopedic Clinics
8.2.3. Others
8.3. Market Attractiveness Analysis, by End-user
9. Global Orthobiologics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Orthobiologics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Demineralized Bone Matrix
10.2.2. Allografts
10.2.3. Synthetic Bone Substitutes
10.2.4. Viscosupplements
10.2.5. Bone Morphogenetic Proteins
10.2.6. Stem Cell Therapy
10.2.7. Others
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Spinal Fusion
10.3.2. Trauma Repair
10.3.3. Reconstructive Surgeries
10.3.4. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Orthopedic Clinics
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Orthobiologics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Demineralized Bone Matrix
11.2.2. Allografts
11.2.3. Synthetic Bone Substitutes
11.2.4. Viscosupplements
11.2.5. Bone Morphogenetic Proteins
11.2.6. Stem Cell Therapy
11.2.7. Others
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Spinal Fusion
11.3.2. Trauma Repair
11.3.3. Reconstructive Surgeries
11.3.4. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Orthopedic Clinics
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Orthobiologics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Demineralized Bone Matrix
12.2.2. Allografts
12.2.3. Synthetic Bone Substitutes
12.2.4. Viscosupplements
12.2.5. Bone Morphogenetic Proteins
12.2.6. Stem Cell Therapy
12.2.7. Others
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Spinal Fusion
12.3.2. Trauma Repair
12.3.3. Reconstructive Surgeries
12.3.4. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Orthopedic Clinics
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Orthobiologics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Demineralized Bone Matrix
13.2.2. Allografts
13.2.3. Synthetic Bone Substitutes
13.2.4. Viscosupplements
13.2.5. Bone Morphogenetic Proteins
13.2.6. Stem Cell Therapy
13.2.7. Others
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Spinal Fusion
13.3.2. Trauma Repair
13.3.3. Reconstructive Surgeries
13.3.4. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Orthopedic Clinics
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Orthobiologics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Demineralized Bone Matrix
14.2.2. Allografts
14.2.3. Synthetic Bone Substitutes
14.2.4. Viscosupplements
14.2.5. Bone Morphogenetic Proteins
14.2.6. Stem Cell Therapy
14.2.7. Others
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Spinal Fusion
14.3.2. Trauma Repair
14.3.3. Reconstructive Surgeries
14.3.4. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Orthopedic Clinics;
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company (2021)
15.3. Company Profiles
15.3.1. Medtronic
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. DePuy Synthes (Johnson & Johnson)
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Sanofi
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Seikagaku Corporation
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Stryker
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. MTF Biologics
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Bioventus LLC
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Arthrex
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Zimmer Biomet
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. RTI Surgical, Inc.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Alphatec Spine, Inc.
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. Exactech, Inc.
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview
15.3.13. Globus Medical, Inc.
15.3.13.1. Company Overview
15.3.13.2. Product Portfolio
15.3.13.3. SWOT Analysis
15.3.13.4. Financial Overview
15.3.13.5. Strategic Overview
15.3.14. Integra LifeSciences
15.3.14.1. Company Overview
15.3.14.2. Product Portfolio
15.3.14.3. SWOT Analysis
15.3.14.4. Financial Overview
15.3.14.5. Strategic Overview
List of Tables
Table 01: Global Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Orthobiologics Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Orthobiologics Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 07: North America Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 08: North America Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 11: Europe Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 12: Europe Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 15: Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 16: Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 19: Latin America Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Latin America Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 23: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 24: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Orthobiologics Market Size (US$ Mn) and Distribution (%), by Region, 2018 and 2031
Figure 02: Global Orthobiologics Market Revenue (US$ Mn), by Product, 2021
Figure 03: Global Orthobiologics Market Value Share, by Product, 2021
Figure 04: Global Orthobiologics Market Value Share, by Application, 2021
Figure 05: Global Orthobiologics Market Value Share, by End-user, 2021
Figure 06: Global Orthobiologics Market Value Share, by Region, 2021
Figure 07: Global Orthobiologics Market Value (US$ Mn) Forecast, 2017–2031
Figure 08: Global Orthobiologics Market Value Share Analysis, by Product, 2017 and 2031
Figure 09: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Bone Morphogenetic Proteins, 2017–2031
Figure 10: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Demineralized Bone Matrix, 2017–2031
Figure 11: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Synthetic Bone Substitutes, 2017–2031
Figure 12: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Viscosupplements, 2017–2031
Figure 13: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Allografts, 2017–2031
Figure 14: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Stem Cell, 2017–2031
Figure 15: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031
Figure 16: Global Orthobiologics Market Attractiveness Analysis, by Product, 2022-2031
Figure 17: Global Orthobiologics Market Value Share Analysis, by Application, 2017 and 2031
Figure 18: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Spinal Fusion, 2017–2031
Figure 19: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Trauma Repair, 2017–2031
Figure 20: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Restorative Surgery, 2017–2031
Figure 21: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031
Figure 22: Global Orthobiologics Market Attractiveness Analysis, by Application, 2022-2031
Figure 23: Global Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2031
Figure 24: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2031
Figure 25: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Orthopedic Clinics, 2017–2031
Figure 26: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031
Figure 27: Global Orthobiologics Market Attractiveness Analysis, by End-user, 2022-2031
Figure 28: Global Orthobiologics Market Value Share Analysis, by Region, 2017 and 2031
Figure 29: Global Orthobiologics Market Attractiveness Analysis, by Region, 2022-2031
Figure 30: North America Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 31: North America Orthobiologics Market Attractiveness Analysis, by Country, 2017–2031
Figure 32: North America Orthobiologics Market Value Share Analysis, by Country, 2017 and 2031
Figure 33: North America Orthobiologics Market Value Share Analysis, by Product, 2017 and 2031
Figure 34: North America Orthobiologics Market Value Share Analysis, by Application, 2017 and 2031
Figure 35: North America Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2031
Figure 36: North America Orthobiologics Market Attractiveness Analysis, by Product, 2022–2031
Figure 37: North America Orthobiologics Market Attractiveness Analysis, by Application, 2022–2031
Figure 38:North America Orthobiologics Market Attractiveness Analysis, by End-user, 2022–2031
Figure 39: Europe Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 40: Europe Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 41: Europe Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
Figure 42: Europe Orthobiologics Market Value Share Analysis, by Product, 2017 and 2031
Figure 43: Europe Orthobiologics Market Value Share Analysis, by Application, 2017 and 2031
Figure 44: Europe Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2031
Figure 45: Europe Orthobiologics Market Attractiveness Analysis, by Product, 2022–2031
Figure 46: Europe Orthobiologics Market Attractiveness Analysis, by Application, 2022–2031
Figure 47: Europe Orthobiologics Market Attractiveness Analysis, by End-user, 2022–2031
Figure 48: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 49: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 50: Asia Pacific Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
Figure 51: Asia Pacific Orthobiologics Market Value Share Analysis, by Product, 2017 and 2031
Figure 52: Asia Pacific Orthobiologics Market Value Share Analysis, by Application, 2017 and 2031
Figure 53: Asia Pacific Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2031
Figure 54: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Product, 2022–2031
Figure 55: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Application, 2022–2031
Figure 56: Asia Pacific Orthobiologics Market Attractiveness Analysis, by End-user, 2022–2031
Figure 57: Latin America Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 58: Latin America Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 59: Latin America Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
Figure 60: Latin America Orthobiologics Market Value Share Analysis, by Product, 2017 and 2031
Figure 61: Latin America Orthobiologics Market Value Share Analysis, by Application, 2017 and 2031
Figure 62: Latin America Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2031
Figure 63: Latin America Orthobiologics Market Attractiveness Analysis, by Product, 2022–2031
Figure 64: Latin America Orthobiologics Market Attractiveness Analysis, by Application, 2022–2031
Figure 65: Latin America Orthobiologics Market Attractiveness Analysis, by End-user, 2022–2031
Figure 66: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 67: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 68: Middle East & Africa Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
Figure 69: Middle East & Africa Orthobiologics Market Value Share Analysis, by Product, 2017 and 2031
Figure 70: Middle East & Africa Orthobiologics Market Value Share Analysis, by Application, 2017 and 2031
Figure 71: Middle East & Africa Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2031
Figure 72: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Product, 2022–2031
Figure 73: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Application, 2022–2031
Figure 74: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by End-user, 2022–2031
Complete the form below and we'll get back to you shortly.
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
